NYSE Euronext Welcomes Movetis N.V. to Its European Market the Largest IPO in Europe of a Pharmaceutical Company Since December 2007

Total Page:16

File Type:pdf, Size:1020Kb

NYSE Euronext Welcomes Movetis N.V. to Its European Market the Largest IPO in Europe of a Pharmaceutical Company Since December 2007 CONTACT | Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris) NYSE Euronext welcomes Movetis N.V. to its European market The largest IPO in Europe of a pharmaceutical company since December 2007 Brussels, 4 December 2009 – Movetis, a Belgian pharmaceutical company, today listed on NYSE Euronext’s Brussels market under the symbol « MOVE ». A total of 19,994,359 Movetis shares were admitted to trading on NYSE Euronext at an introductory price of EUR 12.25 each. The listing resulted from the offer of 13,055,583 existing shares and 6,938,776 new shares, before exercise of the over-allotment option. The amount raised by the initial public offering was EUR 85 million, excluding the over-allotment corresponding to EUR 12.75 million. At the opening, the first market price rose 2.9% to EUR 12.60, bringing the market capitalization of the company at EUR 252 million. Vincent Van Dessel, CEO of NYSE Euronext, Brussels said: ‘We are delighted to welcome Movetis on to NYSE Euronext. This great addition to our market hopefully signals a lasting rebound in the primary market and confirms Brussels as a leading market for biotech and pharmaceutical companies.’ Dirk Reyn, CEO of Movetis added: ‘Movetis is very satisfied with the success of its IPO and is very pleased to be listed on NYSE Euronext as it will enable the company to reach out to an even bigger investment community. It is the start of a new phase in Movetis’ development as a company following the approval in the European Economic Area (EEA) of its lead product Resolor in October of this year.‘ Press contact: +32 2 509 13 92 About Movetis: Movetis (www.movetis.com ) Movetis, a spin-off, was founded in Belgium in November 2006 by senior managers and scientists of former Janssen Pharmaceutica NV (an affiliate of Johnson & Johnson). Movetis is a rapidly growing European specialty pharmaceutical company focused on the discovery, development and commercialisation of novel innovative drugs for the treatment of gastrointestinal diseases with high unmet need. The Company’s lead product Resolor® (prucalopride) has recently received marketing approval from the European Commission for the symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. Movetis expects the first launch of Resolor in Q1 2010. About NYSE Euronext NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With more than 8,000 listed issues, NYSE Euronext's equities markets -- the New York Stock Exchange, NYSE Euronext, NYSE Amex and NYSE Alternext as well as NYSE Arca – represent nearly 40 percent of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, the leading European derivatives business and the world’s second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: http://www.nyx.com .
Recommended publications
  • Intraday Herding on a Cross-Border Exchange
    CORE Metadata, citation and similar papers at core.ac.uk Provided by CURVE/open Intraday Herding on a Cross-Border Exchange Andrikopoulos, P, Kallinterakis, V, Pedro Leite Ferreira, M & Verousis, T Author post-print (accepted) deposited by Coventry University’s Repository Original citation & hyperlink: Andrikopoulos, P, Kallinterakis, V, Pedro Leite Ferreira, M & Verousis, T 2017, 'Intraday Herding on a Cross-Border Exchange' International Review of Financial Analysis, vol 53, pp. 25-36 https://dx.doi.org/10.1016/j.irfa.2017.08.010 DOI 10.1016/j.irfa.2017.08.010 ISSN 1057-5219 Publisher: Elsevier NOTICE: this is the author’s version of a work that was accepted for publication in International Review of Financial Analysis. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in International Review of Financial Analysis, [53, (2017)] DOI: 10.1016/j.irfa.2017.08.010 © 2017, Elsevier. Licensed under the Creative Commons Attribution- NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ Copyright © and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders.
    [Show full text]
  • Filed by the NASDAQ OMX Group, Inc
    Filed by The NASDAQ OMX Group, Inc. (Commission File No. 000-32651) Pursuant to Rule 425 under the Securities Act of 1933, as amended Subject Company: NYSE Euronext (Commission File No. 001-33392) NASDAQ OMX and ICE Issue Joint Statement on Superior Proposal New York, NY and Atlanta, GA (April 25, 2011) NASDAQ OMX (NDAQ) and IntercontinentalExchange (ICE) today issued a joint statement with regard to their superior proposal for NYSE Euronext: NYSE Euronext investors should be highly skeptical that after two years of exploratory merger discussions, including more than six months dedicated to finalizing the transaction, NYSE Euronext has suddenly found a reported €100 million in additional synergies. This increase appears not to be a matter of sharpening a pencil, but an unexplained shift in strategy. The discovery that initial synergies having been understated by one-third comes after receiving a superior proposal from NASDAQ OMX and ICE that achieves greater synergies. Importantly, if there are additional synergies to be found after the merger economics have been agreed, then it has to come at the expense of NYSE Euronext stockholders because there has been no increase in the price they are being offered. NYSE Euronext should describe these newly-found synergies in detail in order to support the credibility of these revised estimates, particularly in light of commitments to retain two technology platforms and two headquarters. Increasingly it appears that NYSE Euronext is more focused on protecting the transaction than its stockholders. NASDAQ OMX and ICE have described in detail our proven and focused long-term strategy from which stockholders would benefit and our companies demonstrated outperformance relative to their proposed strategy of creating a financial supermarket.
    [Show full text]
  • Intercontinental Exchange Reports Ice and Nyse May Volume
    INVESTORS INTERCONTINENTAL EXCHANGE REPORTS ICE AND NYSE MAY VOLUME Released : 04 June 2014 ATLANTA--(BUSINESS WIRE)-- Intercontinental Exchange, Inc. (NYSE: ICE), the leading global network of exchanges and clearing houses, today reported exchange traded volumes for May 2014. ICE’s May average daily volume (ADV) was 5.4 million contracts, a decrease of 15% compared to May 2013. • Commodity futures and options ADV decreased 23% in May due primarily to continued low price volatility across most energy products. • Financial futures and options ADV decreased 9% in May due primarily to the low interest rate environment in Europe. This was partially offset by a 23% increase in equity derivatives ADV year to year, including a 32% increase in Liffe single stock futures. • NYSE cash equities ADV decreased 13% and Euronext cash equities ADV was flat compared to the prior May. NYSE equity options volume decreased 23% year to year. ICE Futures & Options ADV (contracts in 000s) ADV May ADV May Change ADV YTD ADV YTD Change May ’13 2014 2013 y/y May ‘14 y/y COMMODITIES Energy Brent 594 670 -11% 617 712 -13% Gasoil 214 266 -19% 220 272 -19% Other Oil (1) 248 244 2% 254 255 0% TOTAL OIL 1,055 1,179 -10% 1,092 1,239 -12% Natural Gas (2) 714 1,241 -42% 983 1,363 -28% Power (3) 131 141 -7% 130 144 -10% Emissions & Other (4) 32 30 6% 48 46 5% TOTAL ENERGY 1,932 2,591 -25% 2,252 2,792 -19% Agricultural Sugar (5) 115 113 1% 167 146 15% Other Ags & Metals (6) 156 162 -4% 192 188 2% TOTAL AGRICULTURAL & METALS 270 276 -2% 360 334 8% TOTAL COMMODITIES 2,203 2,867 -23% 2,612 3,125 -16% FINANCIALS Interest Rates Short-term Interest Rates (7) 1,729 2,213 -22% 1,761 2,312 -24% Medium & Long-term Interest Rates (8) 195 233 -16% 177 192 -8% TOTAL INTEREST RATES 1,924 2,445 -21% 1,938 2,504 -23% TOTAL EQUITY DERIVATIVES (9) 1,297 1,058 23% 1,051 1,170 -10% TOTAL FX (10) 20 43 -54% 24 38 -38% TOTAL FINANCIALS 3,241 3,547 -9% 3,012 3,712 -19% TOTAL FUTURES & OPTIONS 5,444 6,414 -15% 5,625 6,837 -18% Note: Figures may not foot due to rounding.
    [Show full text]
  • Equity Markets USD 47 Tn
    19 January 2012 2011 WFE Market Highlights 2011 equity volumes remained stable despite a fall in market capitalization. Derivatives, bonds, ETFs, and securitized derivatives continued to grow strongly. Total turnover value remained stable in 2011 at USD 63 tn despite a sharp decrease of the global market capitalization (-13.6% at USD 47 tn). High volatility and global uncertainty created from the sovereign debt crisis affected volumes all year through and made August 2011 the most active month in terms of trading value, a highly unusual annual peak for markets. Despite overall unfavorable conditions for primary markets in several regions, WFE members increased their total listings by 1.7% totaling 45 953 companies listed. Total number of trades decreased by 6.4% at 112 tn. This trend combined with the stability of turnover value led to a small increase in the average size of transaction which was USD 8 700 in 2011. The high volatility and lack of confidence that affected financial markets globally probably drove the needs of hedging as derivatives contracts traded grew by 8.9%. WFE members continued to diversify their products range as other products such as bonds, ETFs, and securitized derivatives all had solid growth in 2011. Equity Markets Market capitalization USD 47 tn -13.6% Domestic market capitalization declined significantly in 2011 to USD 47 401 bn roughly back to the same level of end 2009. The decline affected almost all WFE members, as there were only four exchanges ending 2011 with a higher market capitalization. The magnitude of the decline is quite similar among the three time zones: -15.9% in Asia-Pacific, -15.2% in EAME and -10.8% in the Americas.
    [Show full text]
  • B3 Transfers Equities to Its Multi-Asset Clearing Platform
    Press release 29 August 2017 B3 transfers equities to its multi-asset clearing platform Cinnober’s real-time clearing solution now handles post trading process for both the equities and the derivatives markets in Brazil • BRL 21 billion of collateral returned to the market (approx. USD 6,4 billion) • Phase two completed of major Post-Trade Integration Project going from two clearinghouses to one for equities and derivatives • More efficient risk management by analyzing the risk on entire portfolios B3 (the Brazilian exchange and clearinghouse) successfully launched on Monday the equities, corporate bonds, and equities lending markets on its new multi-asset clearing platform. The clearing solution is delivered by Cinnober, built on its TRADExpress RealTime Clearing system. The migration of the equities clearinghouse was the target for phase two of B3’s Post-Trade Integration Project that will consolidate B3’s originally four clearinghouses into one integrated entity (managing equities, derivatives, government and corporate debt securities and FX). Derivatives and OTC products were the first to launch on the new platform in phase one. With the new integrated clearinghouse, B3 manages risk more efficiently. By analyzing the risk on entire portfolios, the clearinghouse can compensate if an investor has opposite positions in the same underlying asset across product groups and markets. When financial and commodity derivatives, along with OTC products, migrated to the new clearinghouse in phase one, the total systemic benefit in terms of margin release amounted to around BRL 20 billion. The estimated effect from Monday’s launch of phase two is BRL 21 billion of collateral that was returned to the market with complete preservation of the clearinghouse’s safety system.
    [Show full text]
  • Euronext Amsterdam Notice
    DEPARTMENT: Euronext Amsterdam Listing Department ISSUE DATE: Tuesday 13 April 2021 EFFECTIVE DATE: Tuesday 13 April 2021 Document type: Euronext Amsterdam Notice Subject: EURONEXT AMSTERDAM PENALTY BENCH END DATE INTRODUCTION Pursuant to Rule 6903/3, Euronext Amsterdam may decide to include a Security to the Penalty Bench if the Issuer fails to comply with the Rules. This Notice sets out Euronext Amsterdam’s policy with respect to the term a Security can be allocated to the Penalty Bench after which it may be removed from trading. DETAILS Policy for delisting of issuers on the Penalty Bench When Euronext Amsterdam establishes that an Issuer fails to remedy the violation(s) of the Rule(s) that caused the transfer of its instruments to the Penalty Bench and the instruments have been on the Penalty bench for at least 24 months(*), Euronext will consider the violation(s) as a manifest failure of the Issuer to comply with the obligations imposed and the requirements set pursuant to the Rules in accordance with 6905/1(a). The process to come to a decision to remove the Securities will then commence. The final decision will be taken taking all relevant circumstances into account including but not limited to the the investors’ interests and the orderly functioning of the market. The process to delist will be applied in accordance with Rule 6905/1(ii) jo 6905/2 with the following specifications: - The date of the delisting will be at least 6 months after the formal decision. In the meantime, the instrument remains on the Penalty Bench and trading is possible, provided that trading is not suspended.
    [Show full text]
  • I2PO SPAC Lists on Euronext Paris • €275 Million Raised • 16Th SPAC Listing on Euronext in 2021 • 1St European SPAC Dedicated to the Entertainment and Leisure Sector
    Contacts Media Contact Investor Relations Amsterdam +31 20 721 4133 Brussels +32 2 620 15 50 +33 1 70 48 24 27 Dublin +353 1 617 4249 Lisbon +351 210 600 614 Milan +39 02 72 42 62 12 Oslo +47 22 34 19 15 Paris +33 1 70 48 24 45 I2PO SPAC lists on Euronext Paris • €275 million raised • 16th SPAC listing on Euronext in 2021 • 1st European SPAC dedicated to the entertainment and leisure sector Paris – 20 July 2021 – Euronext today congratulates I2PO, a Special Purpose Acquisition Company (SPAC) dedicated to the entertainment and leisure sector, on its listing on the professional compartment of Euronext’s regulated market in Paris (ticker code: I2PO). Iris Knobloch, along with Artemis, a patrimonial holding from the Pinault family represented by François-Henri Pinault and Alban Gréget, and Combat Holding, the entity which co-founded the 2MX Organic and Mediawan SPACs, have partnered to create the I2PO SPAC. The first SPAC in Europe to be co-founded and led by a woman, I2PO is also the first European SPAC in the entertainment and leisure sector. I2PO aims at one or several targets in the sub-sectors such as streaming and content distribution, music, intellectual property of media and services, electronic games and sports, online learning, and leisure platforms. I2PO was listed through the admission to trading of the 27.5 million units making up its equity. In total, I2PO raised €275 million in a private placement from qualified investors, exceeding the €250 million initially announced during the introductory offer. Iris Knobloch, President of the Executive Board and Director General of I2PO, said: “Launching I2PO, we succeeded in creating, with Artemis and Combat Holding, the first SPAC listed in Europe dedicated to entertainment and leisure.
    [Show full text]
  • Case M.9564 – LSEG/REFINITIV BUSINESS REGULATION (EC)
    EUROPEAN COMMISSION DG Competition Case M.9564 – LSEG/REFINITIV BUSINESS Only the English text is available and authentic. REGULATION (EC) No 139/2004 MERGER PROCEDURE Decision on the implementation of the commitments - Purchaser approval Date: 26/2/2021 EUROPEAN COMMISSION Brussels, 26.2.2021 C(2021) 1483 final PUBLIC VERSION In the published version of this decision, some information has been omitted pursuant to Article 17(2) of Council Regulation (EC) No 139/2004 concerning non-disclosure of business secrets and other confidential information. The omissions are shown thus […]. Where possible the information omitted has been replaced by ranges of figures or a general description. London Stock Exchange Group Plc. 10 Paternoster Square EC4M 7LS - London United Kingdom Dear Sir/Madam, Subject: Case M.9564 – LONDON STOCK EXCHANGE GROUP/ REFINITIV BUSINESS Approval of Euronext N.V. as purchaser of the Divestment Business following your letter of 16.10.2020 and the Trustee’s opinion of 22.02.2021 1. FACTS AND PROCEDURE (1) By decision of 13 January 2021 (the "Decision”) based on Article 8(2) of Council Regulation (EC) No 139/20041 and Article 57 of the EEA Agreement2, the 1 OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ("TFEU") has introduced certain changes, such as the replacement of "Community" by "Union" and "common market" by "internal market". The terminology of the TFEU will be used throughout this decision. For the purposes of this Decision, although the United Kingdom withdrew from the European Union as of 1 February 2020, according to Article 92 of the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community (OJ L 29, 31.1.2020, p.
    [Show full text]
  • Bonds Denominated in USD to List for the First Time on NYSE Euronext Lisbon Market BPI Quotes 12 Million on 12Th of March
    CONTACT | Media: CONTACT | Investor Relations: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +1.212.656.5700 (New York) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +33.1.49.27.58.60 (Paris) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris) Bonds denominated in USD to list for the first time on NYSE Euronext Lisbon market BPI quotes 12 million on 12th of March March 11, 2010 – NYSE Euronext (NYX) is pleased to welcome Banco Português de Investimento as the first listed issuer of non-euro currency on Euronext Lisbon. Banco Português de Investimento, a company with a market capitalization of € 1.750 billion, will list two bond issues denominated in USD on the Lisbon market of NYSE Euronext on 12th March 2010: • an issue of USD 6 million of Index Linked Interested Notes “BPI AMERICAN OUTPERFORMANCE 2010-2013” and • an issue of USD 6 million of Index Linked Interest Notes “BPI JPYUSD 350% 2010- 2013”. Both bonds will be issued under the BPI’s Euro Medium Term Note Programme. The listing of these two new products will see the start of a service to trade non-Euro currency via NYSE Euronext in Lisbon. The non-Euro settlement service will be provided by Interbolsa using the non-Euro payment system operated by Caixa Geral de Depósitos. Trading member firms will need to have a clearing member firm (CMF) and a settlement agent (SA) with a settlement account at Interbolsa for the securities side and an account with Caixa Geral de Depósitos for the cash side of the settlement process.
    [Show full text]
  • The Australian Stock Market Development: Prospects and Challenges
    Risk governance & control: financial markets & institutions / Volume 3, Issue 2, 2013 THE AUSTRALIAN STOCK MARKET DEVELOPMENT: PROSPECTS AND CHALLENGES Sheilla Nyasha*, NM Odhiambo** Abstract This paper highlights the origin and development of the Australian stock market. The country has three major stock exchanges, namely: the Australian Securities Exchange Group, the National Stock Exchange of Australia, and the Asia-Pacific Stock Exchange. These stock exchanges were born out of a string of stock exchanges that merged over time. Stock-market reforms have been implemented since the period of deregulation, during the 1980s; and the Exchanges responded largely positively to these reforms. As a result of the reforms, the Australian stock market has developed in terms of the number of listed companies, the market capitalisation, the total value of stocks traded, and the turnover ratio. Although the stock market in Australia has developed remarkably over the years, and was spared by the global financial crisis of the late 2000s, it still faces some challenges. These include the increased economic uncertainty overseas, the downtrend in global financial markets, and the restrained consumer confidence in Australia. Keywords: Stock Market, Australia, Stock Exchange, Capitalization, Stock Market *Corresponding Author. Department of Economics, University of South Africa, P.O Box 392, UNISA, 0003, Pretoria, South Africa Email: [email protected] **Department of Economics, University of South Africa, P.O Box 392, UNISA, 0003, Pretoria, South Africa Email: [email protected] / [email protected] 1. Introduction key role of stock market liquidity in economic growth is further supported by Yartey and Adjasi (2007) and Stock market development is an important component Levine and Zevros (1998).
    [Show full text]
  • Reporting Guidelines
    REPORTING GUIDELINES These guidelines provide the Contracting Party and/or its Affiliates with more detailed information on how to fulfil their market data reporting obligations to Euronext, as described in the EMDA Reporting Policy, as per 1 February 2019. This EMDA Reporting Policy, which forms part of the Euronext Market Data Agreement (EMDA) and other documentation are available here. For more information, please e-mail [email protected]. Note, the information and materials contained in this document are provided ‘as is’ and Euronext does not warrant the accuracy, adequacy or completeness of the information and materials and expressly disclaims liability for any errors or omissions. This document is not intended to be, and shall not constitute in any way a binding or legal agreement, or impose any legal obligation on Euronext. 1 © 2019, Euronext - All rights reserved. Version 1.1 CONTENT Introduction to the Reporting Requirement ................................................................................................. 3 Monthly Reports (submitted via TCB Data) ................................................................................................... 4 TCB Data ............................................................................................................................................................... 4 Display Use of Real Time Market Data ................................................................................................................. 4 Market Data Display Use Fees .............................................................................................................................
    [Show full text]
  • Change to Equity Derivatives Physical Delivery Settlement Cycle
    Transitional Arrangements - Change to Equity Derivatives Physical Delivery Settlement Cycle 1 Exercise/Expiry/Trade 2 Underlying Stock Exchange Current Settlement Cycle New Settlement Cycle Settlement Date Date Futures/Options: Second Borsa Istanbul, Borsa Italiana, Futures/Options: Third Business Thursday 30 June Tuesday 05 July Business Day after Expiry Copenhagen Stock Exchange, Day after Expiry Day/Exercise Day/Exercise Deutsche Boerse, Euronext Amsterdam, Euronext Brussels, Friday 01 July Tuesday 05 July Euronext Lisbon, Euronext Paris, Helsinki Stock Exchange, Irish Stock Exchange, London Stock Exchange, London Stock Exchange (IOB), Oslo Stock Contingent Trades: Stock Contingent Trades: Thursday 30 June Monday 04 July Stock Exchange, SIX Swiss Exchange, Second Business Day after Trade Second Business Day after Trade Stockholm Stock Exchange, Vienna Date Date (no change) Stock Exchange Friday 01 July Tuesday 05 July Futures/Options: Second Futures/Options: Fourth Thursday 30 June Wednesday 06 July Business Day after Expiry Business Day after Expiry Day/Exercise Day/Exercise Friday 01 July Tuesday 05 July Madrid Stock Exchange Stock Contingent Trades: Thursday 30 June Tuesday 05 July Stock Contingent Trades: Third Second Business Day after Trade Business Day after Trade Date Date Friday 01 July Tuesday 05 July Thursday 30 June Thursday 07 July Futures/Options: Fourth Futures/Options: Third Business Business Day after Expiry Day after Expiry Day/Exercise Day/Exercise Friday 01 July Thursday 07 July NYSE, NASDAQ Thursday 30 June Wednesday 06 July Stock Contingent Trades: Third Stock Contingent Trades: Third Business Day after Trade Date Business Day after Trade Date (no change) Friday 01 July Thursday 07 July 1 Effective on and from Friday 01 July 2016 2 For NYSE/NASDAQ, dates reflect the 4th July U.S.
    [Show full text]